Floatz logo

Kenacort

Radiculopathy

University of MiamiSmall moleculePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Radiculopathy cohort.

Asset / SponsorPhaseRating
Lidocaine
Sheba Medical Center
Phase 4BBB
sp-102
Semnur Pharmaceuticals, Inc.
Phase 3BB
Dexasone
Semnur Pharmaceuticals, Inc.
Phase 4BB
Celestone
Sheba Medical Center
Phase 4BB
ARTEMIN
Biogen
Phase 2BB

View all 35 →

Same molecule, other indications

Kenacort is also rated in:

osteoarthritis, kneeActive
BB
Indicative · Phase 4
69 / 100
View asset →
uveal melanomaDormant
BB
Indicative · Phase 4
65 / 100
View asset →
sciaticaActive
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →